Bluejay Diagnostics, Inc.

Medical Devices • Healthcare • Acton, MA, United States • BJDX (NCM)

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. Further, it is developing additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

844 327 7078 360 Massachusetts Avenue, Acton, MA 01720, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Other Medical Devices Companies

View All →

Abbott Laboratories

$218.91B market cap

Boston Scientific Corp.

Edwards Lifesciences Corp.

$51.04B market cap

Dexcom Inc.

$26.50B market cap

Frequently Asked Questions

Has Bluejay Diagnostics, Inc. had layoffs?

No layoff events have been recorded for Bluejay Diagnostics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Bluejay Diagnostics, Inc. have?

Bluejay Diagnostics, Inc. has approximately 7 employees.

What industry is Bluejay Diagnostics, Inc. in?

Bluejay Diagnostics, Inc. operates in the Medical Devices industry, within the Healthcare sector.

Is Bluejay Diagnostics, Inc. a publicly traded company?

Yes, Bluejay Diagnostics, Inc. is publicly traded under the ticker symbol BJDX on the NCM. The company has a market capitalization of approximately $0.00 billion.

Where is Bluejay Diagnostics, Inc. headquartered?

Bluejay Diagnostics, Inc. is headquartered in Acton, MA, United States at 360 Massachusetts Avenue, Acton, MA 01720, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.